Literature DB >> 15865862

Management of diuretic-refractory, volume-overloaded patients with acutely decompensated heart failure.

Jonathan D Sackner-Bernstein1.   

Abstract

Fluid overload is a common presentation for decompensated heart failure, yet management strategies are poorly defined because of relatively few randomized clinical trials that delineate an optimal strategy. Patients refractory to diuretic therapy may be considered for treatment with inotropes or vasodilators, and others may be considered for venovenous ultrafiltration. The rationale for use of each therapy is reviewed.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15865862     DOI: 10.1007/s11886-005-0078-3

Source DB:  PubMed          Journal:  Curr Cardiol Rep        ISSN: 1523-3782            Impact factor:   2.931


  65 in total

1.  Circulatory response to fluid overload removal by extracorporeal ultrafiltration in refractory congestive heart failure.

Authors:  G Marenzi; G Lauri; M Grazi; E Assanelli; J Campodonico; P Agostoni
Journal:  J Am Coll Cardiol       Date:  2001-10       Impact factor: 24.094

2.  Guidelines for the diagnosis and treatment of chronic heart failure.

Authors:  W J Remme; K Swedberg
Journal:  Eur Heart J       Date:  2001-09       Impact factor: 29.983

3.  Incidence, predictors at admission, and impact of worsening renal function among patients hospitalized with heart failure.

Authors:  Daniel E Forman; Javed Butler; Yongfei Wang; William T Abraham; Christopher M O'Connor; Stephen S Gottlieb; Evan Loh; Barry M Massie; Michael W Rich; Lynne Warner Stevenson; James B Young; Harlan M Krumholz
Journal:  J Am Coll Cardiol       Date:  2004-01-07       Impact factor: 24.094

4.  Comparison of dobutamine-based and milrinone-based therapy for advanced decompensated congestive heart failure: Hemodynamic efficacy, clinical outcome, and economic impact.

Authors:  M H Yamani; S A Haji; R C Starling; L Kelly; N Albert; D L Knack; J B Young
Journal:  Am Heart J       Date:  2001-12       Impact factor: 4.749

5.  Chronic infusion of dobutamine and nitroprusside in patients with end-stage heart failure awaiting heart transplantation: safety and clinical outcome.

Authors:  S Capomolla; O Febo; C Opasich; G Guazzotti; A Caporotondi; M T La Rovere; M Gnemmi; A Mortara; M Vona; G D Pinna; R Maestri; F Cobelli
Journal:  Eur J Heart Fail       Date:  2001-10       Impact factor: 15.534

6.  Selective renal vasodilation and active renal artery perfusion improve renal function in dogs with acute heart failure.

Authors:  K Suehiro; J Shimizu; G H Yi; A Gu; J Wang; G Keren; D Burkhoff
Journal:  J Pharmacol Exp Ther       Date:  2001-09       Impact factor: 4.030

7.  A randomized controlled trial of epoprostenol therapy for severe congestive heart failure: The Flolan International Randomized Survival Trial (FIRST).

Authors:  R M Califf; K F Adams; W J McKenna; M Gheorghiade; B F Uretsky; S E McNulty; H Darius; K Schulman; F Zannad; E Handberg-Thurmond; F E Harrell; W Wheeler; J Soler-Soler; K Swedberg
Journal:  Am Heart J       Date:  1997-07       Impact factor: 4.749

8.  Outcome predictors of ultrafiltration in patients with refractory congestive heart failure and renal failure.

Authors:  R Ramos; B I Salem; M P DePawlikowski; M Tariq; M Haikal; T Pohlman; P Mennes
Journal:  Angiology       Date:  1996-05       Impact factor: 3.619

9.  Restoration of renal function in shock by perfusion of the renal artery with venous blood: a counterintuitive approach.

Authors:  David L S Morales; Minoo N Kavarana; David N Helman; John D Madigan; Matthew R Williams; Donald W Landry; Mehmet C Oz
Journal:  Crit Care Med       Date:  2002-06       Impact factor: 7.598

10.  Predischarge initiation of carvedilol in patients hospitalized for decompensated heart failure: results of the Initiation Management Predischarge: Process for Assessment of Carvedilol Therapy in Heart Failure (IMPACT-HF) trial.

Authors:  Wendy A Gattis; Christopher M O'Connor; Dianne S Gallup; Vic Hasselblad; Mihai Gheorghiade
Journal:  J Am Coll Cardiol       Date:  2004-05-05       Impact factor: 24.094

View more
  2 in total

1.  Fluid retention is associated with cardiovascular mortality in patients undergoing long-term hemodialysis.

Authors:  Kamyar Kalantar-Zadeh; Deborah L Regidor; Csaba P Kovesdy; David Van Wyck; Suphamai Bunnapradist; Tamara B Horwich; Gregg C Fonarow
Journal:  Circulation       Date:  2009-01-26       Impact factor: 29.690

Review 2.  Current treatment options for early management in acute decompensated heart failure.

Authors:  Jonathan G Howlett
Journal:  Can J Cardiol       Date:  2008-07       Impact factor: 5.223

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.